These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 719009)

  • 21. A dose-response study in animals to evaluate the anticoagulant effect of the stage 2 unfractionated heparin USP monograph change.
    Honchel R; Carraway J; Gopee N; Callicott R; Chen J; Patton R; Xu Q; Zalkkar J; Laniyonu A; Krefting I; Cato M; Robie-Suh K; Rieves R
    Regul Toxicol Pharmacol; 2011 Aug; 60(3):318-22. PubMed ID: 21549797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assay-dependent kinetics of heparin: evidence for rapid in vivo activation of heparin.
    McGowan FX; Nash PV; Bjornsson TD
    Br J Clin Pharmacol; 1983 Dec; 16(6):677-82. PubMed ID: 6661353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.
    Kazatchkine MD; Fearon DT; Metcalfe DD; Rosenberg RD; Austen KF
    J Clin Invest; 1981 Jan; 67(1):223-8. PubMed ID: 6778897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of interaction between pseudorabies virus and heparan sulfate/heparin.
    Trybala E; Bergström T; Spillmann D; Svennerholm B; Olofsson S; Flynn SJ; Ryan P
    Virology; 1996 Apr; 218(1):35-42. PubMed ID: 8615039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy.
    Casu B; Guerrini M; Naggi A; Torri G; De-Ambrosi L; Boveri G; Gonella S; Cedro A; Ferró L; Lanzarotti E; Paterno M; Attolini M; Valle MG
    Arzneimittelforschung; 1996 May; 46(5):472-7. PubMed ID: 8737629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A collaborative study of heparins from different sources.
    Bangham DR; Woodward PM
    Bull World Health Organ; 1970; 42(1):129-49. PubMed ID: 5309510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulant activity of beef and hog mucosal heparins.
    Aiach M; Kher A; Michaud A; Mardiguian J; Trillou M; Leclerc M
    Thromb Res; 1979 Jan; 14(1):167-77. PubMed ID: 371063
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel method for measurement of heparin anticoagulant activity using SPR.
    Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
    Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative human pharmacology of low molecular weight heparins.
    Harenberg J; Stehle G; Augustin J; Zimmermann R
    Semin Thromb Hemost; 1989 Oct; 15(4):414-23. PubMed ID: 2554502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes.
    Bianchini P; Liverani L; Mascellani G; Parma B
    Semin Thromb Hemost; 1997; 23(1):3-10. PubMed ID: 9156404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.
    Saravanan R
    Adv Food Nutr Res; 2014; 72():45-60. PubMed ID: 25081076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
    Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
    Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase.
    Bertolesi GE; Farías EF; Alonso DF; Bal de Kier Joffé E; Lauría de Cidre S; Eiján AM
    Blood Coagul Fibrinolysis; 1997 Oct; 8(7):403-10. PubMed ID: 9391721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugs.
    Tovar AM; Santos GR; Capillé NV; Piquet AA; Glauser BF; Pereira MS; Vilanova E; Mourão PA
    Sci Rep; 2016 Oct; 6():35619. PubMed ID: 27752111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.